PRA Health Sciences, Inc.
PRA Health Sciences, Inc., a leading global contract research organisation (CRO), is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1976, the company has established itself as a pivotal player in the clinical research industry, providing comprehensive services that span from Phase I to Phase IV clinical trials. PRA Health Sciences offers a unique blend of innovative solutions, including data-driven insights and advanced technology platforms, which enhance the efficiency and effectiveness of clinical development. With a strong focus on therapeutic expertise and patient-centric approaches, the company has achieved notable milestones, including significant partnerships and a robust portfolio of successful trials. Recognised for its commitment to quality and operational excellence, PRA Health Sciences continues to solidify its market position, making it a trusted partner for pharmaceutical and biotechnology companies worldwide.
DitchCarbon Score
How does PRA Health Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PRA Health Sciences, Inc.'s score of 47 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PRA Health Sciences, Inc.'s reported carbon emissions
In 2019, PRA Health Sciences, Inc. reported total carbon emissions of approximately 31,296,000 kg CO2e. This figure includes Scope 1 emissions of about 485,000 kg CO2e, primarily from stationary combustion, and Scope 2 emissions of around 8,456,000 kg CO2e from purchased electricity. The majority of their emissions, approximately 22,355,000 kg CO2e, fall under Scope 3, attributed mainly to business travel. PRA Health Sciences has set ambitious climate commitments, aiming to reduce both Scope 1 and Scope 2 emissions to near zero by 2025. This near-term target reflects their commitment to significantly lower their carbon footprint in the coming years. The company has consistently disclosed emissions data across all three scopes, demonstrating transparency in their environmental impact. Over the years, PRA Health Sciences has shown a trend in emissions management, with total emissions decreasing from about 32,428,000 kg CO2e in 2016 to 31,296,000 kg CO2e in 2019. Their emissions intensity per full-time employee was reported at 1,790 kg CO2e in 2019, indicating a focus on improving operational efficiency alongside emissions reductions. Overall, PRA Health Sciences is actively working towards substantial reductions in their carbon emissions, aligning with industry standards for climate action and sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|
| Scope 1 | - | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 3,945,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 779,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PRA Health Sciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
